Latest SPAC Liquidations: Ibere Pharmaceuticals, New Vista, Kadem Sustainable Impact Corp.
Ibere Pharmaceuticals (IBER) to Liquidate on March 2
Ibere Pharmaceuticals (NYSE:IBER) today announced that it will redeem all of its outstanding ordinary shares that were included in the units issued in its initial public offering, effective as of the close of business on March 2, 2023.
The per-share redemption price for the Public Shares will be approximately $10.17.
The Public Shares will cease trading as of the close of business on March 1, 2023. As of the close of business on March 2, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.
READNew Vista Acquisition Corp. (NVSA) to Liquidate on February 19
New Vista Acquisition Corp. (NASDAQ: NVSA) today announced that it has cancelled the extraordinary general meeting that was previously scheduled for 10:00 a.m. on February 15. The company will not complete an initial business combination by February 19.
Therefore, following February 19, the company will proceed to redeem all of the Class A ordinary shares and will liquidate and dissolve.
The redemption of the Public Shares is expected to be completed by March 6, 2023.
READKadem Sustainable Impact Corp. (KSI) to Liquidate on March 19
Kadem Sustainable Impact Corporation (NASDAQ: KSI) today announced that it will redeem all of its outstanding shares of Class A common stock, effective as of the close of business on March 19.
The per-share redemption price for the public shares will be approximately $10.05.
The company anticipates that the public shares will cease trading as of the open of business on March 17, 2023 in order to allow time for the settlement of trades. As of the close of business on March 19, 2023, the public shares will be deemed cancelled and will represent only the right to receive the Redemption Amount.
READ
Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...
At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...